AN2 Therapeutics SG&A Expense (TTM) Trends

AN2 Therapeutics Inc (ANTX)

2.01 -0.16 (-7.37%) USD | NASDAQ | Jun 17, 13:07

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
March 31, 2024	14.35M
December 31, 2023	14.76M
September 30, 2023	14.59M
June 30, 2023	14.18M
March 31, 2023	14.76M

Date	Value
December 31, 2022	12.75M
September 30, 2022	10.81M
June 30, 2022	9.054M
March 31, 2022	6.317M
December 31, 2021	4.668M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

4.668M

Minimum

Dec 2021

14.76M

Maximum

Dec 2023

11.62M

Average

13.47M

Median

SG&A Expense (TTM) Benchmarks